ConductScience.org, home

Paper36735827

Development of Human Carbonic Anhydrase II Heterobifunctional Degraders.

O'Herin CB and 5 others. J Med Chem, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Development of Human Carbonic Anhydrase II Heterobifunctional Degraders. Papers, record 36735827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36735827

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of Human Carbonic Anhydrase II Heterobifunctional Degraders.
PubMed
Journal
J Med Chem
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.5
iCite
Revised in PubMed
2026-06-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1O'Herin CBConor B
2Moriuchi YWYuta W
3Bemis TATroy A
4Kohlbrand AJAlysia J
5Burkart MDMichael Dhttps://orcid.org/0000-0002-4472-2254
6Cohen SMSeth Mhttps://orcid.org/0000-0002-5233-2280

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carbonic Anhydrase IIMajor topic
Ubiquitin-Protein LigasesMajor topic
Humans
Proteolysis
HEK293 Cells
Proteins

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 GM124169NIGMS NIH HHSUnited StatesP30GM124169PubMed and NIHNIH RePORTER
R01 AI149444NIAID NIH HHSUnited StatesR01AI149444PubMed and NIHNIH RePORTER
R01 GM095970NIGMS NIH HHSUnited StatesR01GM095970PubMedNIH RePORTER
R21 CA273632NCI NIH HHSUnited StatesR21CA273632PubMedNIH RePORTER

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128263557Proteolysis-Targeting Chimeras: Induced Protein Degradation as a Therapeutic Strategy.ACS Chem Biol2017https://conductscience.org/library/papers/28263557PubMed
233568647Mutant-selective degradation by BRAF-targeting PROTACs.Nat Commun2021https://conductscience.org/library/papers/33568647PubMed
327885283Induced protein degradation: an emerging drug discovery paradigm.Nat Rev Drug Discov2017https://conductscience.org/library/papers/27885283PubMed
430729032A chemical approach for global protein knockdown from mice to non-human primates.Cell Discov2019https://conductscience.org/library/papers/30729032PubMed
532435363Discovery of New 1,1'-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II Inhibitors.ACS Med Chem Lett2020https://conductscience.org/library/papers/32435363PubMed
626160114Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.Eur J Med Chem2015https://conductscience.org/library/papers/26160114PubMed
735293758Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells.J Med Chem2022https://conductscience.org/library/papers/35293758PubMed
832840532Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs.Chem Commun (Camb)2020https://conductscience.org/library/papers/32840532PubMed
932969649Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies.J Chem Inf Model2020https://conductscience.org/library/papers/32969649PubMed
117608893Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants.J Med Chem1995https://conductscience.org/library/papers/7608893PubMed
1229129718Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.Cell Chem Biol2018https://conductscience.org/library/papers/29129718PubMed
1316679072The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates.Respir Physiol Neurobiol2006https://conductscience.org/library/papers/16679072PubMed
1418335973Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.Chem Rev2008https://conductscience.org/library/papers/18335973PubMed
1529809145A surface proton antenna in carbonic anhydrase II supports lactate transport in cancer cells.Elife2018https://conductscience.org/library/papers/29809145PubMed
1625043012Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.Nature2014https://conductscience.org/library/papers/25043012PubMed
1721453963Glaucoma.Lancet2011https://conductscience.org/library/papers/21453963PubMed
1820922213Impact of linker length on the activity of PROTACs.Mol Biosyst2011https://conductscience.org/library/papers/20922213PubMed
1935042991PROTAC targeted protein degraders: the past is prologue.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35042991PubMed
2032541897Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.Nat Struct Mol Biol2020https://conductscience.org/library/papers/32541897PubMed
2135507007Developing Metal-Binding Isosteres of 8-Hydroxyquinoline as Metalloenzyme Inhibitor Scaffolds.Inorg Chem2022https://conductscience.org/library/papers/35507007PubMed

See all 48 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42062767Future Directions in Biotechnological and Pharmacological Applications of CAIs.Subcell Biochem2026https://conductscience.org/library/papers/42062767PubMed
42062760Drug Design of Carbonic Anhydrase Inhibitors.Subcell Biochem2026https://conductscience.org/library/papers/42062760PubMed
40911906Data-Driven Generation of Conformational Ensembles and Ternary Complexes for PROTAC and Other Chimera Systems.J Chem Inf Model2025https://conductscience.org/library/papers/40911906PubMed
38404387Programming interchangeable and reversible heterooligomeric protein self-assembly using a bifunctional ligand.Chem Sci2024https://conductscience.org/library/papers/38404387PubMed
37961045
In silico analysis of selected nutrition rich fruit of Bunch berry (Lantana camara) constituents as human acetylcholinesterase (hAchE), carbonic anhydrase II (hCA-II) and carboxylesterase 1 (hCES-1) inhibitory agents.
Saudi J Biol Sci2023https://conductscience.org/library/papers/37961045PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36735827

GET https://conductscience.org/api/papers/v1/36735827/references?page=2